Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,382,189
-
Total 13F shares
-
44,941,395
-
Share change
-
+177,440
-
Total reported value
-
$519,510,481
-
Price per share
-
$11.56
-
Number of holders
-
267
-
Value change
-
-$417,911
-
Number of buys
-
129
-
Number of sells
-
119
Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q3 2025
As of 30 Sep 2025 AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) had 267 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,941,395 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, BROWN ADVISORY INC, STATE STREET CORP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, and AQR CAPITAL MANAGEMENT LLC.
This table shows 267 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.